Metacognitive Therapy vs Unified Protocol for Patients With Comorbid Anxiety Disorders

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKarolinska Institutet

About this trial

The primary goal of this randomized controlled trial is to compare the effectiveness of two transdiagnostic psychological treatments, Metacognitive Therapy (MCT) and the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP), for patients with complex anxiety.

Eligibility criteria

Qualifiers

Age 18 years or above

Ability to read and speak Swedish

A principal diagnosis of post-traumatic stress disorder, generalized anxiety disorder, social anxiety disorder, or panic disorder

At least one additional comorbid diagnosis (one of the above diagnoses, or obsessive-compulsive disorder, or major depressive disorder)

Disqualifiers

Current diagnosis of psychosis, bipolar disorder or moderate to severe substance use disorder

Medium to high suicide risk

Psychiatric, somatic or social problems that require primary intervention other than the treatments offered in the study

Concurrent psychological treatment

Trial design

Treatments tested in this trial

  • Metacognitive therapy (MCT)
  • Unified protocol (UP)

Treatment groups

114 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Karolinska Institutet

Lead sponsor

Region Stockholm

Collaborator